Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.
about
Mapping and deciphering neural codes of NMDA receptor-dependent fear memory engrams in the hippocampusSubstance abuse, memory, and post-traumatic stress disorderNMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats.Glutamate receptors in extinction and extinction-based therapies for psychiatric illnessLearning strategies during fear conditioningFear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25-6981, in mice: attenuation with ageingBehavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory.Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats.NMDA receptor- and ERK-dependent histone methylation changes in the lateral amygdala bidirectionally regulate fear memory formation.Hippocampal NMDA receptor subunits differentially regulate fear memory formation and neuronal signal propagation.NR2B subunit of the NMDA receptor in the basolateral amygdala is necessary for the acquisition of conditioned defeat in Syrian hamstersNR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell deathConcussive brain injury enhances fear learning and excitatory processes in the amygdalaImportance of the GluN2B carboxy-terminal domain for enhancement of social memories.Viral delivery of shRNA to amygdala neurons leads to neurotoxicity and deficits in Pavlovian fear conditioningIncreased NR2A:NR2B ratio compresses long-term depression range and constrains long-term memory.NR2A- and NR2B-containing NMDA receptors in the prelimbic medial prefrontal cortex differentially mediate trace, delay, and contextual fear conditioning.Plasticity of NMDA receptor NR2B subunit in memory and chronic pain.Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.NR2A-Containing NMDARs in the Prefrontal Cortex Are Required for Working Memory and Associated with Age-Related Cognitive Decline.Role of the basolateral amygdala and NMDA receptors in higher-order conditioned fear.The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System.The 5-Hydroxymethylcytosine (5hmC) Reader UHRF2 Is Required for Normal Levels of 5hmC in Mouse Adult Brain and Spatial Learning and Memory.Fear Memory.Perspectives on fear generalization and its implications for emotional disorders.Forebrain NR2B overexpression enhancing fear acquisition and long-term potentiation in the lateral amygdala.Double dissociation of the requirement for GluN2B- and GluN2A-containing NMDA receptors in the destabilization and restabilization of a reconsolidating memory.Dopamine-induced tyrosine phosphorylation of NR2B (Tyr1472) is essential for ERK1/2 activation and processing of novel taste information.Vagus Nerve Stimulation Enhances Extinction of Conditioned Fear in Rats and Modulates Arc Protein, CaMKII, and GluN2B-Containing NMDA Receptors in the Basolateral Amygdala.Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.Ifenprodil reduces excitatory synaptic transmission by blocking presynaptic P/Q type calcium channels.
P2860
Q21559538-3B073A69-3C29-4A53-9C0A-CFE58BF6B177Q30407985-165F7EB6-A65D-4141-9CA9-A0C682034D98Q30444033-454B3AC0-567B-4C13-AE80-36A28DA5753CQ30477927-16B4FC75-4708-4040-B545-8DF017FBFF5BQ30481760-F7F5AF91-65E2-4AEF-917E-C5A748E56BF1Q30484426-D5646A12-D307-4C6D-99AE-43CEBF37ED38Q30524657-0DED7B21-CB76-44A0-8F6E-5065DD2A10EDQ33511242-398E3D70-423C-4D35-88DE-F570EA8240F2Q33770536-AE80E31D-EE2D-4414-8AD5-E9A446400068Q33939116-A4E7746F-E27C-4146-9E51-E7140D0893D8Q34419877-294EBDDB-7E54-4ECD-8C2C-A4ACA8FEE916Q34559448-C8BF5314-AEA7-416C-8C09-70B333E1D913Q35690731-4C0CA757-536A-4049-BA95-5FB95E4EEE5AQ35875795-E19F1738-F24C-4E61-BF45-84157F421EF7Q36055122-71DC2412-16B6-4E31-85A5-74F55D8038BFQ36515061-7E4DB6E5-1CE3-4FA9-8265-1C23C3A0708FQ36914507-49644772-BD5B-4A65-ADF8-4CF10E517843Q37385159-3D8E6779-ECC8-4D66-9908-5585AB6D17AFQ37491564-BE994C8E-4C16-407F-8F3C-E0C744075FACQ37504950-E1DF0D6C-2A32-46E5-AE32-804005B47312Q37876896-E54842EE-5811-42AB-BB92-71D4DAC7B79AQ38707263-A02CCD85-D8CA-4772-8A5E-3D5CAC6AFF2FQ38719819-E6AAD0F7-240A-4E59-BCC0-5C3590FCFDA5Q38777375-FE662A95-9550-4AD3-A76C-5B12901FC8D7Q38905664-63F1E6F3-39E9-4252-9B96-1E6F8835EA6EQ40789286-348C2EB6-0860-4734-8718-58555267E184Q41821754-16EF35D1-CBDB-4C49-9CE1-0378753AEEB9Q41895336-1842DDD0-2650-41F6-BF1A-9413F256245DQ42364462-08B4AFA3-270D-4B7B-8F56-BB5DD1B966B8Q48262180-31C1D746-5A7D-4113-86AE-4DAB4C64917AQ48742959-ADA8EB24-3B00-4153-83ED-9A2F4A4FB08B
P2860
Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@ast
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@en
type
label
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@ast
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@en
prefLabel
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@ast
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@en
P2860
P356
P1433
P1476
Amygdala infusions of an NR2B- ...... fear-potentiated startle test.
@en
P2093
David L Walker
Michael Davis
P2860
P356
10.1101/LM.798908
P577
2008-01-28T00:00:00Z